Record-Breaking Price Surge
On 14 May 2026, Integrated Proteins Ltd’s share price touched Rs.120.30, marking a new 52-week and all-time high. This peak represents a substantial increase from its 52-week low of Rs.20.71, translating to a staggering 480.88% rise from the lowest point within the past year. The stock’s recent momentum is further highlighted by a consecutive nine-day gain, during which it delivered a cumulative return of 15.51%.
The stock outperformed its sector peers on the day, registering a 0.46% gain compared to the Sensex’s 0.26% rise and outperforming the solvent extraction segment, which declined by 2.47%. Over the past week, Integrated Proteins Ltd advanced by 6.89%, while the Sensex fell by 3.91%. The one-month performance was even more pronounced, with the stock surging 42.10% against a Sensex decline of 2.66%.
Long-Term Performance Highlights
Integrated Proteins Ltd’s price appreciation over longer horizons is particularly notable. The stock has delivered a 172.79% return over the past year, vastly outpacing the Sensex’s negative 8.02% performance. Year-to-date gains stand at an impressive 249.71%, while the three-month return is an extraordinary 288.06%, compared to the Sensex’s 9.47% decline.
Over a three-year period, the stock has appreciated by 1,103.00%, dwarfing the Sensex’s 20.60% gain. The ten-year performance is even more remarkable, with a 5,521.50% increase, far exceeding the Sensex’s 193.47% rise. These figures illustrate the company’s sustained growth trajectory and its ability to generate substantial shareholder value over time.
Technical Indicators Signal Bullish Momentum
The technical outlook for Integrated Proteins Ltd remains strongly bullish. The stock is trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling robust upward momentum. The overall technical trend shifted to bullish on 27 March 2026, when the price crossed ₹71.33, marking a clear breakout from a prior sideways trend.
Key technical indicators reinforce this positive stance. The weekly and monthly MACD and Bollinger Bands are bullish, while the weekly KST and Dow Theory indicators also support the upward trend. The Relative Strength Index (RSI) shows a bearish signal on the weekly chart but no signal on the monthly, suggesting some short-term caution amid the broader positive trend.
Immediate support is established at the 52-week low of ₹20.71, while resistance levels previously noted at ₹103.03 (20-day moving average) and ₹54.98 (100-day moving average) have been decisively surpassed. The stock’s current price at the 52-week high of ₹120.30 represents a far resistance level, underscoring the strength of the rally.
Valuation Metrics Reflect Elevated Multiples
At the current price of Rs.120.30, Integrated Proteins Ltd’s valuation multiples indicate a premium positioning. The trailing twelve months (TTM) price-to-earnings (P/E) ratio stands at a high 679x, reflecting elevated expectations relative to earnings. The price-to-book value (P/BV) ratio is 11.01x, while the enterprise value to EBITDA and EBIT multiples are both at 224.10x, signalling a stretched valuation on traditional profitability metrics.
The enterprise value to sales ratio is 8.72x, and the EV to capital employed ratio matches the P/BV at 11.01x. Dividend metrics are not applicable, with no dividend yield or payout reported. These valuation figures suggest that the market is pricing in significant growth and performance, consistent with the stock’s recent price trajectory.
Quality Assessment and Financial Trends
Integrated Proteins Ltd’s overall quality grade is classified as below average, based on long-term financial performance. The company exhibits average growth with a five-year sales compound annual growth rate (CAGR) of 92.87%, but EBIT growth over the same period is modest at 7.26%. The average EBIT to interest ratio is weak at -0.05x, though the company maintains negligible debt levels with an average debt to EBITDA ratio of 0.46 and net debt to equity at zero, indicating low leverage.
Return on capital employed (ROCE) and return on equity (ROE) are weak, at -5.14% and 1.51% respectively. The tax ratio stands at 21.43%, and there is no dividend payout. Notably, the company has no promoter share pledging and low institutional holdings, which may be relevant for shareholder structure considerations.
Short-term financial trends as of December 2025 are flat, with quarterly earnings per share (EPS) at a low of ₹-0.06. Delivery volumes have increased significantly, with a 45.7% rise in one-day delivery compared to the five-day average and a 35.49% increase over the trailing one-month period, reflecting heightened trading activity accompanying the price rally.
Sector Context and Market Capitalisation
Integrated Proteins Ltd operates within the edible oil industry, a sector that has experienced mixed performance recently. While the solvent extraction segment declined by 2.47% on the day of the stock’s all-time high, Integrated Proteins Ltd outperformed both its sector and the broader market indices. The company is classified as a micro-cap, which often entails higher volatility but also potential for significant price movements.
The stock’s ability to sustain gains above all major moving averages and its strong relative performance against the Sensex and sector peers highlight its current market strength.
Summary of Market and Technical Performance
Integrated Proteins Ltd’s stock price reaching Rs.120.30 on 14 May 2026 marks a historic high for the company, reflecting a powerful rally driven by consistent gains over recent months and years. The stock’s outperformance relative to the Sensex and sector peers, combined with bullish technical indicators and increased delivery volumes, underscores the strength of this milestone.
While valuation multiples remain elevated and quality assessments indicate areas for improvement, the company’s long-term sales growth and strong balance sheet provide context for the current market enthusiasm. This achievement represents a significant chapter in Integrated Proteins Ltd’s market journey, highlighting its evolution within the edible oil sector.
